Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Barratt

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Frontiers in Aging|May 15, 2026
Utilizing age-friendly cities and communities to support access to vaccination, vision, hearing and oral healthcareCera Cruise, Katrina Bouzanis, Anna Sangster, et al.
Acta Diabetologica|March 31, 2020
Fundamental principles of an effective diabetic retinopathy screening programPaolo Lanzetta, Valentina Sarao, Peter H Scanlon, et al.
Acta Diabetologica|May 19, 2020
Correction to: Fundamental principles of an effective diabetic retinopathy screening programPaolo Lanzetta, Valentina Sarao, Peter H Scanlon, et al.
Eye (London, England)|December 16, 2025
Development and standardisation of 'time-in-range' measurement for clinical endpoints in retinal diseasesLuisa Frizziero, Jane Barratt, Chui Ming Gemmy Cheung, et al.
Ophthalmology|August 9, 2020
Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: A Mixed-Methods Systematic ReviewMali Okada, Paul Mitchell, Robert P Finger, et al.
Ophthalmology and Therapy|December 16, 2022
The Patient Voice in Neovascular Age-Related Macular Degeneration: Findings from a Qualitative StudyS James Talks, Vincent Daien, Paul Mitchell, et al.
Vaccine|July 25, 2020
A global agenda for older adult immunization in the COVID-19 era: A roadmap for actionLois A Privor-Dumm, Gregory A Poland, Jane Barratt, et al.
Aging and Disease|June 14, 2018
Aging Health and R&D for Healthy Longevity Must Be Included into the WHO Work ProgramIlia Stambler, Kunlin Jin, Stephanie Lederman, et al.
Expert Review of Vaccines|July 8, 2021
The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policyLindsay R Grant, Mary P E Slack, Qi Yan, et al.
JAMA Ophthalmology|June 3, 2021
Defining Nonadherence and Nonpersistence to Anti-Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular DegenerationMali Okada, Tien Yin Wong, Paul Mitchell, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Aging|May 15, 2026
Utilizing age-friendly cities and communities to support access to vaccination, vision, hearing and oral healthcareCera Cruise, Katrina Bouzanis, Anna Sangster, et al.
Acta Diabetologica|March 31, 2020
Fundamental principles of an effective diabetic retinopathy screening programPaolo Lanzetta, Valentina Sarao, Peter H Scanlon, et al.
Acta Diabetologica|May 19, 2020
Correction to: Fundamental principles of an effective diabetic retinopathy screening programPaolo Lanzetta, Valentina Sarao, Peter H Scanlon, et al.
Eye (London, England)|December 16, 2025
Development and standardisation of 'time-in-range' measurement for clinical endpoints in retinal diseasesLuisa Frizziero, Jane Barratt, Chui Ming Gemmy Cheung, et al.
Ophthalmology|August 9, 2020
Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: A Mixed-Methods Systematic ReviewMali Okada, Paul Mitchell, Robert P Finger, et al.
Ophthalmology and Therapy|December 16, 2022
The Patient Voice in Neovascular Age-Related Macular Degeneration: Findings from a Qualitative StudyS James Talks, Vincent Daien, Paul Mitchell, et al.
Vaccine|July 25, 2020
A global agenda for older adult immunization in the COVID-19 era: A roadmap for actionLois A Privor-Dumm, Gregory A Poland, Jane Barratt, et al.
Aging and Disease|June 14, 2018
Aging Health and R&D for Healthy Longevity Must Be Included into the WHO Work ProgramIlia Stambler, Kunlin Jin, Stephanie Lederman, et al.
Expert Review of Vaccines|July 8, 2021
The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policyLindsay R Grant, Mary P E Slack, Qi Yan, et al.
JAMA Ophthalmology|June 3, 2021
Defining Nonadherence and Nonpersistence to Anti-Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular DegenerationMali Okada, Tien Yin Wong, Paul Mitchell, et al.
Pageof 4